Enveric Biosciences, Inc. (ENVB)

1.47 +0.06 (+4.26%) USD  |  NASDAQ  |  Aug 25, 13:08
More

Enveric Biosciences EPS Estimates for Current Fiscal Year

EPS Estimates for Current Fiscal Year Chart

View EPS Estimates for Current Fiscal Year for ENVB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Estimates for Current Fiscal Year Chart
Start Trial

Historical EPS Estimates for Current Fiscal Year Data

View and export this data back to 2023. Start Trial.
Date Value
July 02, 2024 --
May 20, 2024 --
April 02, 2024 --
March 26, 2024 --
December 29, 2023 --
December 07, 2023 --
Date Value
November 20, 2023 --
October 03, 2023 --
August 31, 2023 --
August 24, 2023 --
July 13, 2023 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Fiscal Year Range, Past 5 Years

View EPS Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Current Fiscal Year Benchmarks

View EPS Estimates for Current Fiscal Year Benchmarks
Start Trial
LENZ Therapeutics, Inc. Upgrade
Impact BioMedical, Inc. --
ANI Pharmaceuticals, Inc. Upgrade
Corcept Therapeutics, Inc. Upgrade
Veru, Inc. Upgrade

EPS Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Next Fiscal Year Upgrade